Metabolic effects of portal vein sensing

被引:24
作者
Mithieux, G. [1 ,2 ,3 ]
机构
[1] Fac Med Lyon Est Laennec, INSERM, U855, F-69372 Lyon 08, France
[2] Univ Lyon 1, Fac Med Lyon Est Laennec, F-69622 Villeurbanne, France
[3] Univ Lyon, Fac Med Lyon Est Laennec, Lyon, France
关键词
diabetes; gastrointestinal neural system; gluconeogenesis; intestine; obesity; portal vein; protein-enriched diet; soluble fibre; GLUCAGON-LIKE PEPTIDE-1; FOOD-INTAKE; INTESTINAL GLUCONEOGENESIS; GLUCOSE-TOLERANCE; DIABETES-MELLITUS; OPIOID RECEPTORS; DIETARY FIBER; PROTEIN; HEALTH; RATS;
D O I
10.1111/dom.12338
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The extrinsic gastrointestinal nerves are crucial in the sensing of nutrients and hormones and its translation in terms of control of food intake. Major macronutrients like glucose and protein are sensed by the extrinsic nerves located in the portal vein walls, which signal to the brain and account for the satiety phenomenon they promote. Glucose is sensed in the portal vein by neurons expressing the glucose receptor SGLT3, which activate the main regions of the brain involved in the control of food intake. Proteins indirectly act on food intake by inducing intestinal gluconeogenesis and its sensing by the portal glucose sensor. The mechanism involves a prior antagonism by peptides of the -opioid receptors present in the portal vein nervous system and a reflex arc with the brain inducing intestinal gluconeogenesis. In a comparable manner, short-chain fatty acids produced from soluble fibre act via intestinal gluconeogenesis to exert anti-obesity and anti-diabetic effects. In the case of propionate, the mechanism involves a prior activation of the free fatty acid receptor FFAR3 present in the portal nerves and a reflex arc initiating intestinal gluconeogenesis.
引用
收藏
页码:56 / 60
页数:5
相关论文
共 37 条
  • [1] The inhibitory effects of peripheral administration of peptide YY3-36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway
    Abbott, CR
    Monteiro, M
    Small, CJ
    Sajedi, A
    Smith, KL
    Parkinson, JRC
    Ghatei, MA
    Bloom, SR
    [J]. BRAIN RESEARCH, 2005, 1044 (01) : 127 - 131
  • [2] ANDERSON JW, 1984, P SOC EXP BIOL MED, V177, P372
  • [3] Intake suppression after hepatic portal glucose infusion: All-or-none effect and its temporal threshold
    Baird, JP
    Grill, HJ
    Kaplan, JM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1997, 272 (05) : R1454 - R1460
  • [4] Anatomy and function of sensory hepatic nerves
    Berthoud, HR
    [J]. ANATOMICAL RECORD PART A-DISCOVERIES IN MOLECULAR CELLULAR AND EVOLUTIONARY BIOLOGY, 2004, 280A (01): : 827 - 835
  • [5] Gut-brain signalling: how lipids can trigger the gut
    Breen, Danna M.
    Yang, Clair S.
    Lam, Tony K. T.
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2011, 27 (02) : 113 - 119
  • [6] Design of mu selective opioid dipeptide antagonists
    Capasso, A
    Amodeo, P
    Balboni, G
    Guerrini, R
    Lazarus, LH
    Temussi, PA
    Salvadori, S
    [J]. FEBS LETTERS, 1997, 417 (01) : 141 - 144
  • [7] Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes
    Clore, JN
    Stillman, J
    Sugerman, H
    [J]. DIABETES, 2000, 49 (06) : 969 - 974
  • [8] The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats
    Date, Y
    Murakami, N
    Toshinai, K
    Matsukura, S
    Niijima, A
    Matsuo, H
    Kangawa, K
    Nakazato, M
    [J]. GASTROENTEROLOGY, 2002, 123 (04) : 1120 - 1128
  • [9] Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits
    De Vadder, Filipe
    Kovatcheva-Datchary, Petia
    Goncalves, Daisy
    Vinera, Jennifer
    Zitoun, Carine
    Duchampt, Adeline
    Backhed, Fredrik
    Mithieux, Gilles
    [J]. CELL, 2014, 156 (1-2) : 84 - 96
  • [10] Hypothalamic integration of portal glucose signals and control of food intake and insulin sensitivity
    Delaere, F.
    Magnane, C.
    Mithieux, G.
    [J]. DIABETES & METABOLISM, 2010, 36 (04) : 257 - 262